3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Terminated
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
3
Other hematologic neoplasm
1
Lymphoid
1
Head & Neck
1
Dermatologic
1
Conditions
Keratosis, Actinic
1
Interventions
Nivolumab
26
pembrolizumab
22
Ipilimumab
16
Temozolomide
13
toripalimab
12
Biopsy
10
Cyclophosphamide
9
Imiquimod
8
Dacarbazine
7
Blood Specimen Collection
7
camrelizumab
6
Chemotherapy, Adjuvant
6
trametinib
5
fludarabine
5
dabrafenib
5
atezolizumab
5
aldesleukin
5
Gene Expression Profiling
5
Cisplatin
5
Aminolevulinic Acid
5
fludarabine phosphate
4
durvalumab
4
binimetinib
4
apatinib
4
Tomography, Optical Coherence
4
Sorafenib
4
Photochemotherapy
4
Interleukin-2
4
Injections
4
Bevacizumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Melatonin
×
Dermatologic
×
Clear all
NCT05740969
2023-02-23
PACKS
Zealand University Hospital
Phase 2
Unknown
48 enrolled